Presentation TCT 2017 Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy? Presenter: C. Michael Gibson, Stephan Windecker, Eric R. Bates October 30, 2017
Presentation TCT 2017 Interventional Pharmacology Strategies for PCI and ACS Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Piera Capranzano October 29, 2017
Presentation TCT 2017 Interventional Pharmacology: A Guideline-based Review Presenter: Jose de Ribamar Costa Jr, Jose L. Leiva-Pons, Dominick J. Angiolillo October 29, 2017
Presentation TCT 2017 Patients First Encounter, Tele-medicine and Interventional Approach Presenter: Jose de Ribamar Costa Jr, Jose L. Leiva-Pons, Jamil Cade October 29, 2017
Presentation TCT 2017 DAPT Duration: Individualized vs Generalized Approach Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Marco Valgimigli October 29, 2017
Presentation TCT 2017 Consideration of Prolonged DAPT After DES Deployment From Angioscopic Findings Presenter: Takeshi Kimura, Shigeru Saito, Takafumi Ueno October 29, 2017
Presentation TCT 2017 Dose Adjustment of Prasugrel for PCI for Japanese Patient Presenter: Takeshi Kimura, Shigeru Saito, Masato Nakamura October 29, 2017
Presentation TCT 2016 Opening Salvo: I Don't Believe That Door-to-Balloon Time Is a Critical Metric for Primary PCI In 2016! Presenter: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung, Hitinder S. Gurm November 01, 2016
Presentation TCT 2016 2016 DAPT Update: Evidence and Guidelines Presenter: Sripal Bangalore, George D. Dangas, Adnan K. Chhatriwalla November 01, 2016
Presentation TCT 2016 Opening Salvo: I Don't Believe That DAPT Should Be Continued Beyond 12 Months in Most Patients Undergoing PCI! Presenter: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung, Gennaro Giustino November 01, 2016
Presentation TCT 2016 Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, Ongoing Studies Presenter: George D. Dangas, Debabrata Mukherjee, C. Michael Gibson November 01, 2016
Presentation TCT 2016 Deciding on the Duration of DAPT Presenter: George D. Dangas, Debabrata Mukherjee, Neal S. Kleiman November 01, 2016
Presentation TCT 2016 TCT 56: Validation of PARIS Risk Scores in a Large Multi-Ethnic PCI Cohort: Results From a Large Single-Center Registry Presenter: Neal S. Kleiman, David F. Kong, Usman Baber October 31, 2016
Presentation TCT 2016 TCT 55: RiskBenefit Analysis of Upstream Antithrombotic Therapy in Patients With NonST-Segment Elevation Acute Coronary Syndromes Prior to Coronary Angiography Presenter: Neal S. Kleiman, David F. Kong, Bjorn Redfors October 31, 2016
Presentation TCT 2016 TCT 54: LEADERS FREE OAC: Biolimus A9 Coated vs Bare Metal Stents in Patients Requiring Oral Anticoagulation. A Prespecified Subgroup Analysis of the LEADERS FREE Trial Presenter: Neal S. Kleiman, David F. Kong, Didier Carrié October 31, 2016
Presentation TCT 2016 TCT 53: Thromboembolic Event Rate Is Elevated With Lower Adherence to Warfarin and NOACs Presenter: Neal S. Kleiman, David F. Kong, Jeffrey R Winterfield October 31, 2016
Presentation TCT 2016 TCT 7: Relationship Between Traditional Risk Factors, Platelet Reactivity, and Thrombotic Events: A Mediation Analysis From ADAPT-DES Presenter: Dimitrios Alexopoulos, Laurent Bonello, Bjorn Redfors October 31, 2016
Presentation TCT 2016 TCT 8: Impact of Aspirin Resistance on Outcomes After Coronary Events Presenter: Dimitrios Alexopoulos, Laurent Bonello, Christine Chung October 31, 2016
Presentation TCT 2016 TCT 6: Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 Inhibitors in Contemporary PCI: Results From a Large Single-Center Registry Presenter: Dimitrios Alexopoulos, Laurent Bonello, Usman Baber October 31, 2016
Presentation TCT 2016 TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY Trial Presenter: Dimitrios Alexopoulos, Laurent Bonello, Ramin Ebrahimi October 31, 2016